SCHEMBL7315399

SCHEMBL7315399

CCOc1ccc(CC#N)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 3/20 0.56
MAPT P10636 3/20 0.51
KDM4E B2RXH2 2/20 0.51
GAA P10253 2/20 0.51
TP53 P04637 2/20 0.49
LMNA P02545 2/20 0.49
PDE4A P27815 2/20 0.48
PDE4B Q07343 2/20 0.48
PDE4C Q08493 2/20 0.48
PDE4D Q08499 2/20 0.48
TSHR P16473 1/20 0.47
CA2 P00918 1/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.47
RECQL P46063 1/20 0.47
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
PIK3CD O00329 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7253321 0.93 PDE4A (0.52) CALM1MAPTKDM4EPDE4APDE4B
SCHEMBL2967916 0.91 CALM1 (0.45) CALM1MAPTKDM4EGAALMNA
SCHEMBL77974 0.88 CA2 (0.61) KDM4ETSHRCA2ALDH1A1PIK3CD
SCHEMBL7311427 0.86 MAPT (0.46) MAPTKDM4ETP53LMNAPDE4A
SCHEMBL7367373 0.85 CA2 (0.46) CALM1MAPTKDM4EGAALMNA
SCHEMBL2972012 0.85 CALM1 (0.41) CALM1MAPTKDM4EGAATP53
SCHEMBL21328358 0.84 CA2 (0.52) KDM4ETSHRCA2ALDH1A1PIK3CD
SCHEMBL13250648 0.84 FDPS (0.49) CALM1MAPTKDM4ECA2MEN1
SCHEMBL7320184 0.83 S1PR2 (0.51) ALDH1A1HPGD
SCHEMBL10827884 0.83 ALDH1A1 (0.46) CALM1MAPTKDM4EGAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252721-B1 4-NITROGEN SUBSTITUTED ISOQUINOLINOL COMPOUNDS HAVING CARDIOTONIC, PHOSPHODIESTERASE FRACTION III INHIBITING PROPERTIES AND/OR RENAL VASODILATING PROPERTIES ORTHO PHARMACEUTICAL CORPORATION (US) 1991-10-02 EP disclosed
US-4880817-A O-functionalized derivatives of substituted isoquinolin-3-ols having cardiotonic and/or phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-11-14 US disclosed
US-4822800-A Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1989-04-18 US disclosed
EP-0252721-A1 4-Nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1988-01-13 EP disclosed
US-4714705-A 4-nitrogen substituted isoquinolinol compounds having cardiotonic, phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties ORTHO PHARMACEUTICAL CORPORATION (US) 1987-12-22 US disclosed